Is retinoic acid an endogenous ligand during urodele limb regeneration?

Int J Dev Biol

Ludwig Institute for Cancer Research, University College London, United Kingdom.

Published: August 1996

The effects of retinoids on a regenerating urodele limb make them interesting candidates for endogenous ligands during regeneration. We review the evidence for considering this possibility. This includes analysis of retinoids and retinoic acid receptors in the regenerate, and studies on activation of retinoid reporter genes. Recent work has provided evidence that the wound epidermis is a source of 9-cis retinoic acid, and may be a favorable model for studying the synthesis and release of this modulator.

Download full-text PDF

Source

Publication Analysis

Top Keywords

retinoic acid
12
urodele limb
8
acid endogenous
4
endogenous ligand
4
ligand urodele
4
limb regeneration?
4
regeneration? effects
4
effects retinoids
4
retinoids regenerating
4
regenerating urodele
4

Similar Publications

Acne and acne sequelae can have an important impact on patients' quality of life, affecting interpersonal relationships and social functioning. Acne-induced scars (AIS) and acne-induced macular hyperpigmentation (AIH), in particular, are a major concern for patients with acne, as their management is challenging and often unsatisfactory. Retinoids are considered the mainstay of acne treatment because of their action on multiple pathogenetic factors, and there is increasing evidence that they can also improve AIS and AIH.

View Article and Find Full Text PDF

Drug Development.

Alzheimers Dement

December 2024

Olabisi Onabanjo University, Sagamu, Ogun, Nigeria.

Background: Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid beta proteins to form plaques and the aggregation of hyperphosphorylated tau to form neurofibrillary tangles. Human fibroblast (SH-SY5Y) cells endogenously express Tau, and the expression is further amplified upon differentiation into neuronal cells, making it a cell model of Alzheimer's disease. Nigella sativa oil (NSO) contains 50% thymoquinone and has been used in the treatment of various nervous system disorders.

View Article and Find Full Text PDF

Drug Development.

Alzheimers Dement

December 2024

Deakin University, Geelong, VIC, Australia.

Background: Reliable treatment approaches for addressing early cognitive impairment and Alzheimer's disease (AD) are currently lacking. Given the multifactorial nature of AD, therapeutic strategies need to focus on disease-specific biochemical pathways. Given the significance of metabolic pathways in cognitive impairment, it is essential to investigate alternative disease modifiers capable of targeting multiple metabolic pathways, such as phytochemicals.

View Article and Find Full Text PDF

Deficiency of Epithelial PIEZO1 Alleviates Liver Steatosis Induced by High-Fat Diet in Mice.

Int J Biol Sci

January 2025

Division of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.

PIEZO1 has been found to play a vital role in regulating intestinal epithelial cells (IEC) function and maintaining intestinal barrier in recent years. Therefore, IEC PIEZO1 might exert a significant impact on liver metabolism through the gut-liver axis, but there is no research on this topic currently. Classic high-fat diet (HFD) model and mice with IEC-specific deficiency of PIEZO1 ( ) were used to explore the problem.

View Article and Find Full Text PDF

Ponatinib, a tyrosine kinase inhibitor used for chronic myeloid leukemia and acute lymphoblastic leukemia, can cause rare cutaneous side effects. In this case, a 63-year-old woman developed a pityriasis rubra pilaris-like eruption 1 month after starting the drug. The skin reaction improved with dose reduction and recurred more mildly at a lower dose.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!